Isomer-specific effects of conjugated linoleic acid on gene expression in RAW 264.7.

[1]  J. Peters,et al.  The oxidative stress mediator 4-hydroxynonenal is an intracellular agonist of the nuclear receptor peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) , 2007 .

[2]  T. Langmann,et al.  Isomer specific effects of Conjugated Linoleic Acid on macrophage ABCG1 transcription by a SREBP-1c dependent mechanism. , 2007, Biochemical and biophysical research communications.

[3]  M. Rydén,et al.  A role of lipin in human obesity and insulin resistance: relation to adipocyte glucose transport and GLUT4 expression Published, JLR Papers in Press, October 11, 2006. , 2007, Journal of Lipid Research.

[4]  Takuji Tanaka,et al.  Potent inhibitory effect of trans9, trans11 isomer of conjugated linoleic acid on the growth of human colon cancer cells. , 2006, The Journal of nutritional biochemistry.

[5]  G. Fernandes,et al.  Biological effects of conjugated linoleic acids in health and disease. , 2006, The Journal of nutritional biochemistry.

[6]  John P. Vanden Heuvel,et al.  Differential Activation of Nuclear Receptors by Perfluorinated Fatty Acid Analogs and Natural Fatty Acids: A Comparison of Human, Mouse, and Rat Peroxisome Proliferator-Activated Receptor-α, -β, and -γ, Liver X Receptor-β, and Retinoid X Receptor-α , 2006 .

[7]  H. Roche,et al.  Profound resolution of early atherosclerosis with conjugated linoleic acid. , 2006, Atherosclerosis.

[8]  S. Heys,et al.  Induction of apoptosis and inhibition of NF‐κB activation in human prostate cancer cells by the cis‐9, trans‐11 but not the trans‐10, cis‐12 isomer of conjugated linoleic acid , 2006 .

[9]  K. Matsushima,et al.  Absence of IL-1 Receptor Antagonist Impaired Wound Healing along with Aberrant NF-κB Activation and a Reciprocal Suppression of TGF-β Signal Pathway1 , 2006, The Journal of Immunology.

[10]  M. Tsujimoto,et al.  Endothelial scavenger receptors. , 2006, Progress in lipid research.

[11]  S. Lim,et al.  Trans-10,cis-12, not cis-9,trans-11, conjugated linoleic acid inhibits G1-S progression in HT-29 human colon cancer cells. , 2006, The Journal of nutrition.

[12]  Michael M Lieber,et al.  PDLIM4 repression by hypermethylation as a potential biomarker for prostate cancer. , 2006, Clinical cancer research : an official journal of the American Association for Cancer Research.

[13]  H. Steinhart,et al.  CLA isomers inhibit TNFα-induced eicosanoid release from human vascular smooth muscle cells via a PPARγ ligand-like action , 2006 .

[14]  J. Kuliczkowska-Płaksej,et al.  [The influence of diabetes mellitus and insulin resistance on receptor CD36 expression. Part II. The role of receptor CD36 in the pathomechanism of diabetes complications]. , 2006, Postepy higieny i medycyny doswiadczalnej.

[15]  Jerzy K. Kulski,et al.  Gene expression profiling of Japanese psoriatic skin reveals an increased activity in molecular stress and immune response signals , 2005, Journal of Molecular Medicine.

[16]  A. Davies,et al.  ABCA1 and atherosclerosis , 2005, Vascular medicine.

[17]  B. Clurman,et al.  Cyclin E in normal and neoplastic cell cycles , 2005, Oncogene.

[18]  S. Heys,et al.  Effect of CLA supplementation on immune function in young healthy volunteers , 2005, European Journal of Clinical Nutrition.

[19]  H. Gronemeyer,et al.  Characterization of the Interaction between Retinoic Acid Receptor/Retinoid X Receptor (RAR/RXR) Heterodimers and Transcriptional Coactivators through Structural and Fluorescence Anisotropy Studies* , 2005, Journal of Biological Chemistry.

[20]  G. Peros,et al.  Prognostic evaluation of CD44 expression in correlation with bcl-2 and p53 in colorectal cancer. , 2005, Folia histochemica et cytobiologica.

[21]  Roger A. Davis,et al.  Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARα, β/δ, and γ , 2004 .

[22]  A. Ridley,et al.  Why three Rho proteins? RhoA, RhoB, RhoC, and cell motility. , 2004, Experimental cell research.

[23]  S. Heys,et al.  Conjugated linoleic acids: are they beneficial or detrimental to health? , 2004, Progress in lipid research.

[24]  Haw‐Wen Chen,et al.  Contribution of conjugated linoleic acid to the suppression of inflammatory responses through the regulation of the NF-κB pathway , 2004 .

[25]  B. Jeffy,et al.  Conjugated linoleic acid inhibits cell proliferation through a p53-dependent mechanism: effects on the expression of G1-restriction points in breast and colon cancer cells. , 2003, The Journal of nutrition.

[26]  H. Aukema,et al.  Dietary conjugated linoleic acid reduces PGE2 release and interstitial injury in rat polycystic kidney disease. , 2003, Kidney international.

[27]  Jerry T. Thompson,et al.  Synthesis of a high-affinity fluorescent PPARgamma ligand for high-throughput fluorescence polarization assays. , 2003, Bioorganic & medicinal chemistry.

[28]  J. V. Vanden Heuvel,et al.  Comprehensive gene expression analysis of peroxisome proliferator-treated immortalized hepatocytes: identification of peroxisome proliferator-activated receptor alpha-dependent growth regulatory genes. , 2003, Cancer research.

[29]  S. Døskeland,et al.  Mitochondrial-targeted fatty acid analog induces apoptosis with selective loss of mitochondrial glutathione in promyelocytic leukemia cells. , 2003, Chemistry & biology.

[30]  W. Christie,et al.  Advances in Conjugated Linoleic Acid Research , 2003 .

[31]  M. Furuse,et al.  Dietary conjugated linoleic acid reduces cerebral prostaglandin E2 in mice , 2003, Neuroscience Letters.

[32]  Koji Yamada,et al.  Immunoglobulin and cytokine production from spleen lymphocytes is modulated in C57BL/6J mice by dietary cis-9, trans-11 and trans-10, cis-12 conjugated linoleic acid. , 2003, The Journal of nutrition.

[33]  M. Cook,et al.  Dietary Conjugated Linoleic Acid Decreased Cachexia, Macrophage Tumor Necrosis Factor-α Production, and Modifies Splenocyte Cytokines Production1 , 2003, Experimental biology and medicine.

[34]  L. Madsen,et al.  Impact of mitochondrial beta-oxidation in fatty acid-mediated inhibition of glioma cell proliferation. , 2003, Journal of lipid research.

[35]  Jutta Heim,et al.  A microarray-based, integrated approach to identify novel regulators of cancer drug response and apoptosis , 2002, Oncogene.

[36]  D. Ma,et al.  An Enriched Mixture of Trans-10,Cis-12-CLA Inhibits Linoleic Acid Metabolism and PGE2 Synthesis in MDA-MB-231 Cells , 2002, Nutrition and cancer.

[37]  J. Martin,et al.  Conjugated linoleic acids: all the same or to everyone its own function? , 2002, Reproduction, nutrition, development.

[38]  W. Arend.  The balance between IL-1 and IL-1Ra in disease. , 2002, Cytokine & growth factor reviews.

[39]  B. Mackey,et al.  Similar effects of c9, t11-CLA and t10,c12-CLA on immune cell functions in mice , 2002, Lipids.

[40]  K. Kristiansen,et al.  Tetradecylthioacetic acid prevents high fat diet induced adiposity and insulin resistance. , 2002, Journal of lipid research.

[41]  J. Heuvel,et al.  Conjugated linoleic acid decreases production of pro-inflammatory products in macrophages: evidence for a PPARγ-dependent mechanism , 2002 .

[42]  M. Sugano,et al.  Conjugated Linoleic Acid Reduces Body Fats and Cytokine Levels of Mice , 2002, Bioscience, biotechnology, and biochemistry.

[43]  M. McGuire,et al.  Estimation of conjugated linoleic acid intake by written dietary assessment methodologies underestimates actual intake evaluated by food duplicate methodology. , 2001, The Journal of nutrition.

[44]  K. Kristiansen,et al.  Modulation of keratinocyte gene expression and differentiation by PPAR-selective ligands and tetradecylthioacetic acid. , 2001, The Journal of investigative dermatology.

[45]  K. Thirunavukkarasu,et al.  ADAMTS-1: A cellular disintegrin and metalloprotease with thrombospondin motifs is a target for parathyroid hormone in bone. , 2000, Endocrinology.

[46]  H. Nishimatsu,et al.  ADAMTS-1: a metalloproteinase-disintegrin essential for normal growth, fertility, and organ morphology and function. , 2000, The Journal of clinical investigation.

[47]  G. Stangl.  High dietary levels of a conjugated linoleic acid mixture alter hepatic glycerophospholipid class profile and cholesterol-carrying serum lipoproteins of rats. , 2000, The Journal of nutritional biochemistry.

[48]  C. Stanton,et al.  Milk fat conjugated linoleic acid (CLA) inhibits growth of human mammary MCF-7 cancer cells. , 2000, Anticancer research.

[49]  D. Fowlkes,et al.  Dissection of the LXXLL Nuclear Receptor-Coactivator Interaction Motif Using Combinatorial Peptide Libraries: Discovery of Peptide Antagonists of Estrogen Receptors α and β , 1999, Molecular and Cellular Biology.

[50]  B. Denecke,et al.  RGS1 Is Expressed in Monocytes and Acts as a GTPase-activating Protein for G-protein-coupled Chemoattractant Receptors* , 1999, The Journal of Biological Chemistry.

[51]  J. V. Vanden Heuvel,et al.  Conjugated linoleic acid is a potent naturally occurring ligand and activator of PPARalpha. , 1999, Journal of lipid research.

[52]  K. Thompson,et al.  Dietary conjugated linoleic acids promote fatty streak formation in the C57BL/6 mouse atherosclerosis model , 1999, British Journal of Nutrition.

[53]  J. V. Vanden Heuvel,et al.  Dietary conjugated linoleic acid normalizes impaired glucose tolerance in the Zucker diabetic fatty fa/fa rat. , 1998, Biochemical and biophysical research communications.

[54]  B. Seed,et al.  PPAR-γ agonists inhibit production of monocyte inflammatory cytokines , 1998, Nature.

[55]  C. Gabay,et al.  Interleukin-1 receptor antagonist: role in biology. , 1998, Annual review of immunology.

[56]  L. Luedecke,et al.  Survey of the conjugated linoleic acid contents of dairy products. , 1995, Journal of dairy science.

[57]  D. Hogg,et al.  Cell cycle dependent regulation of the protein kinase TTK. , 1994, Oncogene.

[58]  W. Arend.  Interleukin-1 receptor antagonist. , 1993, Advances in immunology.

[59]  W. Arend.  Interleukin 1 receptor antagonist. A new member of the interleukin 1 family. , 1991, The Journal of clinical investigation.

[60]  R. Thompson,et al.  Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist. , 1990, The Journal of clinical investigation.

[61]  M. Pariza,et al.  Conjugated dienoic derivatives of linoleic acid: A new class of anticarcinogens , 1990, Medical oncology and tumor pharmacotherapy.

[62]  B. Mach,et al.  A urine inhibitor of interleukin 1 activity affects both interleukin 1 alpha and 1 beta but not tumor necrosis factor alpha. , 1987, Journal of immunology.